EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma

Miki Usui iD, Katsunori Uchida iD, Aoi Hayasaki, Masashi Kishiwada, Shugo Mizuno iD, Masatoshi Watanabe

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Miki Usui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Several reports have shown the importance of margins in pancreatoduodenectomy (PD) specimens; however, whether anterior surfaces are included as margins varies among reports. In this study, we aimed to examine the impact of the anterior surface on disease-free survival (DFS) and overall survival (OS).

Method

In total, 98 patients who underwent PD after chemoradiotherapy for pancreatic ductal adenocarcinoma at Mie University Hospital between January 1, 2012, and December 31, 2019, were included. We investigated the prognostic impact of the distance from the anterior surface to tumor cells on DFS and OS using a log-rank test. Multivariate analysis was performed using Cox proportional hazards analysis.

Results

A significant difference in DFS and OS was observed up to a distance of 5 mm from the anterior surface of tumor cells. The multivariate analysis revealed that the distance from the anterior surface to tumor cells (≤5 mm) was an independent poor prognostic factor for DFS and OS.

Conclusion

In patients with PD treated with neoadjuvant therapy, the distance from the anterior surface to tumor cells is an important assessment and should be included in the pathology report.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreaticoduodenectomyCarcinoma, Pancreatic DuctalPancreatic NeoplasmsNeoadjuvant TherapyHumansFemaleMaleAgedMiddle AgedPrognosisDisease-Free SurvivalChemoradiotherapyRetrospective StudiesMargins of ExcisionAged, 80 and overAdult

Autor:innen und Institutionen

  • Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Department of Pathology, Kansai Medical University, Hirakata, Osaka, Japan.
  • Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Mie University School of Medicine, Tsu, Mie, Japan.

ORCID-Profile: Miki Usui, Katsunori Uchida, Shugo Mizuno

Zitieren

APA

Usui, M., Uchida, K., Hayasaki, A., Kishiwada, M., Mizuno, S., & Watanabe, M. (2024). Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0307876

Vancouver

Usui M, Uchida K, Hayasaki A, Kishiwada M, Mizuno S, Watanabe M. Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0307876

BibTeX
@article{Usui2024,
  author = {Usui, Miki and Uchida, Katsunori and Hayasaki, Aoi and Kishiwada, Masashi and Mizuno, Shugo and Watanabe, Masatoshi},
  title = {Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307876}
}
Kostenlos starten →